Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,079 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma

NCT01335399

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution - 1628 Birmingham, Alabama, United States
  • Local Institution - 7619 Mobile, Alabama, United States
  • Local Institution - 7618 Mobile, Alabama, United States
  • Local Institution - 7617 Chandler, Arizona, United States
View all 235 locations
View Trial Details
Completed

A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma

NCT01677858

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Comprehensive Blood and Cancer Center (CCBC) Bakersfield, California, United States
  • California Cancer Associates for Research and Excellence Encinitas, California, United States
  • Robert A. Moss, M.D., FACP, Inc. Fountain Valley, California, United States
View all 35 locations
View Trial Details
Completed

Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma

NCT02412878

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Research Site Scottsdale, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Research Site Bethesda, Maryland, United States
  • Center for Cancer and Blood Disorders Bethesda, Maryland, United States
View all 140 locations
View Trial Details
Completed

Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma

NCT01080391

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • Providence St. Joseph Medical Center Burbank, California, United States
  • St. Jude Hospital Yorba Linda dba; St. Joseph Heritage Healthcare Santa Rosa, California, United States
  • Stanford University Stanford, California, United States
View all 127 locations
View Trial Details
Completed

Multiple Myeloma Minimal Residual Disease

NCT02627261

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Hôpital Huriez Lille, France
  • Centre Hospitalier Universitaire Hôtel-Dieu de Nantes Nantes, France
  • Centre Hospitalier Lyon Sud Pierre Bénité, France
View Trial Details

Related conditions